Wnt signaling in colorectal cancer: pathogenic role and therapeutic target
H Zhao, T Ming, S Tang, S Ren, H Yang, M Liu, Q Tao… - Molecular cancer, 2022 - Springer
Abstract Background The Wnt signaling pathway is a complex network of protein interactions
that functions most commonly in embryonic development and cancer, but is also involved in …
that functions most commonly in embryonic development and cancer, but is also involved in …
The functional roles of the circRNA/Wnt axis in cancer
CircRNAs, covalently closed noncoding RNAs, are widely expressed in a wide range of
species ranging from viruses to plants to mammals. CircRNAs were enriched in the Wnt …
species ranging from viruses to plants to mammals. CircRNAs were enriched in the Wnt …
Signaling pathways governing breast cancer stem cells behavior
K Song, M Farzaneh - Stem Cell Research & Therapy, 2021 - Springer
Breast cancer is the second common cancer and the leading cause of malignancy among
females overall. Breast cancer stem cells (BCSCs) are a small population of breast cancer …
females overall. Breast cancer stem cells (BCSCs) are a small population of breast cancer …
Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy
M Van Trimpont, E Peeters, Y De Visser, AM Schalk… - Cancers, 2022 - mdpi.com
Simple Summary L-asparaginase (L-ASNase) therapy is key for achieving the very high cure
rate of pediatric acute lymphoblastic leukemia (ALL), yet its use is mostly confined to this …
rate of pediatric acute lymphoblastic leukemia (ALL), yet its use is mostly confined to this …
[HTML][HTML] A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Background Triple-negative breast cancer (TNBC) is a heterogeneous, aggressive
phenotype of breast cancer with associated chemoresistance. The development of chemo-or …
phenotype of breast cancer with associated chemoresistance. The development of chemo-or …
Therapeutic progress and challenges for triple negative breast cancer: Targeted therapy and immunotherapy
Triple negative breast cancer (TNBC) is a subtype of breast cancer, with estrogen receptor,
human epidermal growth factor receptor 2 and progesterone receptor negative. TNBC is …
human epidermal growth factor receptor 2 and progesterone receptor negative. TNBC is …
Curcumin: modulator of key molecular signaling pathways in hormone-independent breast cancer
R Farghadani, R Naidu - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer remains the most commonly diagnosed cancer and the
leading cause of cancer death among females worldwide. It is a highly heterogeneous …
leading cause of cancer death among females worldwide. It is a highly heterogeneous …
Triple-negative breast cancer: understanding Wnt signaling in drug resistance
P Merikhian, MR Eisavand, L Farahmand - Cancer cell international, 2021 - Springer
Triple-negative breast cancer (TNBC) is not as prevalent as hormone receptor or HER2-
positive breast cancers and all receptor tests come back negative. More importantly, the …
positive breast cancers and all receptor tests come back negative. More importantly, the …
Immunotherapy in breast cancer: when, how, and what challenges?
B Henriques, F Mendes, D Martins - Biomedicines, 2021 - mdpi.com
Breast Cancer (BC) is the second most frequent cause of cancer death among women
worldwide and, although there have been significant advances in BC therapies, a significant …
worldwide and, although there have been significant advances in BC therapies, a significant …
Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways
The efficacy of STING (stimulator of interferon genes) agonists is due to various factors,
primarily inefficient intracellular delivery, low/lack of endogenous STING expression in many …
primarily inefficient intracellular delivery, low/lack of endogenous STING expression in many …